Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 8:05 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2377–2400 of 13,940 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Trial Clear all

Conditions: Irritable Bowel Syndrome
Interventions: Blautix, Placebo; Biological · Other
Lead sponsor: 4D pharma plc; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 366 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 24
States / cities: Huntsville, Alabama • Phoenix, Arizona • North Hollywood, California + 21 more

Conditions: Dental Caries
Interventions: Silver Diamine Fluoride, Fluoride Varnishes, Glass Ionomer; Device
Lead sponsor: NYU College of Dentistry; Other
Eligibility: 5 Years to 12 Years
Enrollment: 3,345 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: Obesity, Non-Alcoholic SteatoHepatitis (NASH)
Interventions: Survodutide, Placebo; Combination Product
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years and older
Enrollment: 218 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 33
States / cities: Fountain Valley, California • Gardena, California • Long Beach, California + 29 more

Conditions: Multiple Myeloma, Lymphoma, Transplant-Related Disorder
Interventions: Feedback; Behavioral
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Postoperative Ileus
Interventions: Daikenchuto (TU-100), Placebo; Drug
Lead sponsor: Tsumura USA; Industry
Eligibility: 18 Years and older
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 13
States / cities: Los Angeles, California • Aurora, Colorado • Weston, Florida + 10 more

Conditions: Healthy Volunteers, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Interventions: ALN-PNP, Placebo (PB); Drug
Lead sponsor: Regeneron Pharmaceuticals; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 172 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 6
States / cities: Glendale, California • Los Angeles, California • Miami, Florida + 2 more

Conditions: Stress Urinary Incontinence
Interventions: Transcutaneous electrical stimulation (Elitone); Device
Lead sponsor: Elidah, Inc.; Industry
Eligibility: 21 Years to 75 Years · Female only
Enrollment: 87 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Monroe, Connecticut

Conditions: Hypertension, Cardiovascular Diseases, Cardiovascular Risk Factors, Circadian Rhythms, Sleep
Interventions: At-home Polysomnography, Circadian Protocol, Rested Wakefulness Trial, Overnight Sleep Trial, Regularized Sleep Schedule; Other · Behavioral
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 25 Years to 64 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2029
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Breastfeeding
Interventions: Telemedicine Support, Standard of Care; Behavioral · Other
Lead sponsor: University of California, Davis; Other
Eligibility: Not listed
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Very Low Birth Weight Infant
Interventions: cord milking; Other
Lead sponsor: University of California, Los Angeles; Other
Eligibility: Up to 32 Weeks
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Diabetes, Gestational
Interventions: Metformin, Placebo; Drug
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 49 Years · Female only
Enrollment: 114 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 2
States / cities: Houston, Texas

Conditions: Influenza
Interventions: CAIV-T, Liquid; Biological
Lead sponsor: MedImmune LLC; Industry
Eligibility: 6 Months to 18 Months
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2001
U.S. locations: 1
States / cities: Monroe, Wisconsin

Conditions: Herpes Simplex Labialis
Interventions: Zicam (Ionic zinc), placebo; Drug
Lead sponsor: Integrative Medicine Institute; Other
Eligibility: 18 Years to 65 Years
Enrollment: 157 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 3
States / cities: Tempe, Arizona • Santa Fe, New Mexico • New York, New York

Conditions: Scarring, Spinal Stenosis, Herniated Disc
Interventions: Lumbar Decompression Surgery, Microdiscectomy Surgery, Dehydrated Human Amnion/Chorion Membrane (dHACM); Procedure · Other
Lead sponsor: MiMedx Group, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 143 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Uveitis, Uveitis, Posterior, Uveitis, Anterior, Uveitis, Intermediate, Panuveitis
Interventions: 4mg CLS-TA Suprachoriodal Injection, Sham Procedure; Drug
Lead sponsor: Clearside Biomedical, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 40
States / cities: Phoenix, Arizona • Tucson, Arizona • Bakersfield, California + 36 more

Conditions: Diarrhea, Gastroenteritis
Interventions: Zinc Sulfate, Placebo oral capsule; Drug
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 6 Months to 6 Years
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Atopic Dermatitis
Interventions: Lebrikizumab, Placebo; Biological · Other
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 12 Years and older
Enrollment: 445 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 40
States / cities: Scottsdale, Arizona • Rogers, Arkansas • Bakersfield, California + 35 more

Conditions: Chronic Cough
Interventions: ADX-629, Placebo; Drug
Lead sponsor: Aldeyra Therapeutics, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 14
States / cities: San Diego, California • San Jose, California • Hollywood, Florida + 11 more

Conditions: Time Restricted Eating, Obesity, Weight Loss, Colorectal Cancer
Interventions: Time restricted eating, Calorie Restriction; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 45 Years to 70 Years
Enrollment: 194 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Hypophosphatemia, Renal Transplant
Interventions: Cinacalcet, Placebo; Drug
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2015
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: NSAID (Non-Steroidal Anti-Inflammatory Drug), Lumbar Spine Fusion, Ketorolac, Postoperative Pain
Interventions: Ketorolac, Naproxen, Standard Postoperative Pain Management; Drug · Other
Lead sponsor: Rothman Institute Orthopaedics; Other
Eligibility: 18 Years and older
Enrollment: 428 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Stress Disorders, Post-Traumatic, Combat Disorders, Sleep Disorders
Interventions: prazosin hydrochloride, placebo; Drug
Lead sponsor: Seattle Institute for Biomedical and Clinical Research; Other
Eligibility: 18 Years and older
Enrollment: 67 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 2
States / cities: Seattle, Washington • Tacoma, Washington

Conditions: Otitis Media
Interventions: telithromycin (HMR3647); Drug
Lead sponsor: Sanofi; Industry
Eligibility: 6 Months to 59 Months
Enrollment: 639 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: Bridgewater, New Jersey

Conditions: Familial Dysautonomia
Interventions: CBT sessions, Talking Sessions; Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 80 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

A Trial for New Treatment of Adult Participants With Irritable Bowel Syndrome

Comparative Effectiveness of Treatments to Prevent Dental Caries

A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight (SYNCHRONIZE-MASLD)

Stepping Up: A Trial of Activity Monitoring Devices in Patients Undergoing Autologous Stem Cell Transplant

Effect of TU-100 in Patients Undergoing Laparoscopic Colectomy

A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Stress Incontinence Trial With Elitone Device

Sleep and Circadian Mechanisms in Hypertension

LIFT: Telemedicine Breastfeeding Support

Cord Milking Impacts Neurodevelopmental Outcomes in Very Low Birth Weight Infants

Metformin Postpartum for GDM RCT for Reduced Weight Retention

Trial to Investigate Viral Shedding in Healthy Children Vaccinated With Vaccine Virus Liquid (CAIV-T)

Zinc for the Treatment of Herpes Simplex Labialis (HSL)

dHACM in Lumbar Decompression and Microdiscectomy Surgery

Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis

Oral Zinc for the Treatment of Acute Diarrhea in US Children

Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis

A Clinical Trial to Evaluate the Safety and Efficacy in Subjects With Chronic Cough

Time-restricted Eating Versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers

Using Cinacalcet to Treat the Hypophosphatemia of Early Kidney Transplant

NSAIDS Following Elective Lumbar Spine Fusion

Augmentation Trial of Prazosin for Post-Traumatic Stress Disorder (PTSD)

Comparative Study to Evaluate the Efficacy and Safety of Telithromycin Given Once Daily Versus Cefuroxime Axetil Given Twice Daily in Children With Middle Ear Infections

Telemedicine Clinical Trial for Cognitive Behavioral Therapy in Familial Dysautonomia